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To the Editor: Devic et al. (1) investigated the use of fixed thresholds to define NSCLC tumors 
PET volumes exhibiting heterogeneous uptake. They found no correlation between the CT-based 
and the PET-based volumes, and associated the observed variations with intrinsic properties of 
PET acquisition rather than their segmentation choice. They also concluded that PET-based 
volumes should not be used for radiotherapy dose painting/boosting. Several studies recently 
dealt with similar issues (2,3) by considering fixed threshold to determine tumor metabolic 
volumes, demonstrating variability in the threshold values. Other recent studies demonstrated the 
limitations of fixed threshold and proposed more accurate and robust methods, from adaptive 
thresholding (4,5) to advanced algorithms (6-8) capable in some cases of handling heterogeneous 
uptake frequently characterizing tumors treated with radiotherapy.  
Fixed thresholds cannot reliably define functional volumes due to their deterministic and 
binary nature whereas tumor uptake is variable, spatially heterogeneous and dependent on a large 
number of acquisition and reconstruction parameters. We agree that additional studies are needed 
to better characterize the correlation between tracer uptake and underlying metabolism. However, 
irrespectively of such correlation, differentiation of a PET volume from its background is an 
image segmentation issue that cannot be rigorously addressed using threshold-based 
methodologies. Those lead to inconsistent tumor volumes in most of the realistic clinical cases 
(1-5), especially heterogeneous ones (1,5,8). In these cases and in the absence of appropriate 
segmentation tools, it may be more accurate (although less reproducible) to rely on manual 
delineation rather than fixed threshold.  
The use of inappropriate segmentation tools will lead to misleading conclusions regarding 
the potential of FDG PET in guiding radiotherapy treatment planning or as a prognostic and 
predictive factor for therapy response (9). As new algorithms become available and the clinical 
research applications demonstrate their potential, the medical equipment and software industry 
should implement them. Societies should develop minimum standards and guidelines regarding 
functional volumes segmentation, first in clinical research and eventually in clinical practice. 
This is a slow process and misleading conclusions as a result of the use of inappropriate 
approaches will reduce the interest of the technique, slowing even further the process of making 
available new technology. We therefore suggest a more radical stance with avoiding the use of 
any fixed threshold based definition of PET metabolic tumor volumes in the future, especially if 
they are to be used for any PET image guided therapy application. 
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